Researchers at MHH want to study the altered lipid metabolism in patients with PPCM and find new biomarkers for diagnosis and therapy.

Using innovative photon-counting computed tomography, a team of radiologists at MHH has developed a new technique for imaging the lungs.

A research group in the sociology of medicine studies the development of health in the population and comes to surprising results.

Great success in the Shanghai ranking: reputation of the divisional university strengthened.

A European consortium with the participation of the MHH is developing a new tool to determine the individual risk of liver fibrosis and liver cancer.

Vascular prostheses made from the blood protein fibrin: The biocompatible alternative to synthetic plastic prostheses is now to be made increasingly…

MHH molecular physician Professor Dr. Dr. Schambach wants to find new therapeutic options against three particularly malignant cancers.

In MS, misdirected immune cells damage the sheaths of the nerve cells in the brain. Researchers at the MHH have discovered a repair mechanism.

Garbers would like to network the previous research foci of glycobiochemistry and diabetology more closely together with cytokine research.

Dr. Alice Rovai receives the publication award of the German Liver Foundation.